Siepen, F. a. d., Hein, S., Hofmann, E., Nagel, C., Schwarting, S. K., Hegenbart, U., . . . Kristen, A. (2024). Prognostic value of standard heart failure medication in patients with cardiac transthyretin amyloidosis. Journal of Clinical Medicine, 13(8), . https://doi.org/10.3390/jcm13082257
Chicago-Zitierstil (17. Ausg.)Siepen, Fabian aus dem, et al. "Prognostic Value of Standard Heart Failure Medication in Patients with Cardiac Transthyretin Amyloidosis." Journal of Clinical Medicine 13, no. 8 (2024). https://doi.org/10.3390/jcm13082257.
MLA-Zitierstil (9. Ausg.)Siepen, Fabian aus dem, et al. "Prognostic Value of Standard Heart Failure Medication in Patients with Cardiac Transthyretin Amyloidosis." Journal of Clinical Medicine, vol. 13, no. 8, 2024, https://doi.org/10.3390/jcm13082257.